We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microchip Separates White Blood Cells from Whole Blood

By LabMedica International staff writers
Posted on 14 Aug 2013
A new microchip can quickly separate white blood cells from samples of whole blood, eliminating any preliminary processing steps, which could make it difficult to integrate into point-of-care medical devices.

The scientists aim is to integrate the microchip into a portable diagnostic device that may be used to directly analyze patient blood samples for signs of inflammatory disease such as sepsis—particularly in regions of developing countries where diagnostic lab equipment is not readily available. More...


The scientists pumped tiny volumes of blood through the microchip and recovered a highly pure stream of white blood cells, virtually devoid of other blood components such as platelets and red blood cells. The team found that the sorted cells were undamaged and functional, potentially enabling clinicians not only to obtain a white blood cell count, but also to use the cells to perform further genetic or clinical tests.

The chip works by mimicking the physiological process of “cell rolling” where patterns of adhesive molecules are used to draw out neutrophils from a stream of blood into a parallel buffer stream. For blood samples, Prof. Karnik, Rohit Karnik, an associate professor of mechanical engineering at Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Suman Bose worked in parallel on a new microchip design. The team etched a pattern of microscopically thin gold stripes, diagonal to the flow of fluid through the chip. They then attached molecules of P-selectin along each gold stripe. Before flowing blood through the chip, the team tested the design with a culture of two types of leukemia cells. Through video imaging, they observed that one cell type was drawn out of the stream, attaching and rolling briefly along a sticky gold stripe before jumping to a neighboring line. Eventually, after a series of jumps and rolls, the cells rolled the rest of the way along a stripe, then into a separate gutter, or channel, where they flowed into a collector.

Rohit Karnik, an associate professor of mechanical engineering at MIT, said that the key to recovering such pure, functional cells lies in the microchip’s adaption of the body’s natural process of cell rolling.

“We believe that because we’re using a very biomimetic process, the cells are happier,” said Prof. Karnik an associate professor of mechanical engineering at MIT, “It’s a more gentle process, and the cells are functionally viable.” Prof. Karnik and colleagues published their results in the July 2013 issue of the journal Scientific Reports.

Related Links:
Massachusetts Institute of Technology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Slide Scanner System
NanoZoomer S540MD
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.